| Name | Title | Contact Details |
|---|
RxWiki Inc. is a rapidly growing Digital Health company connecting pharmacies and patients through its Digital Pharmacist (www.digitalpharmacist.com) SaaS platform and original Pharmacist written and verified content. RxWiki`s Digital Pharmacist platform powers the websites and mobile applications of 1,300 specialty and community pharmacy brands. Patients can manage their medications, complete digital refills and engage with medication adherence programs. RxWiki`s original Pharmacist written and verified content includes 20,000 original health articles, 7,500 health-related videos, and 100 disease condition channels. More than 3,700 community pharmacies and national health brands, like Health Mart and Health Media Network, license this content to engage and educate their patients. The company is headquartered in Austin, Texas.
Darena Solutions delivers an ecosystem of FHIR® enabled interoperability, regulatory compliance, and analytics solutions to healthcare providers and payers. By creating channels for data sharing between providers, payers, and patients, our solutions enable healthcare organizations to achieve compliance and derive insights to make prospective decisions resulting in increased workflow efficiencies and better patient outcomes.
Novitas Solutions is a Camp Hill, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.
Brevium is a South Jordan, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.